- Population Screening for vCJD Using a Novel Blood Test
- Chief Medical Officer appoints Professor Rossor as NIHR National Director for Dementia Research
- New partnership between UCLP brain tumour scientists and Brain Tumour Research
- Professor Hardy awarded Dan David Prize for work on the amyloid gene encoding APP
- NIHR award £650,000 for research into rare neurodegenerative and neuromuscular diseases
- Lowering levels of toxic protein reverses abnormalities in cells from patients with Huntington's disease
- Major initiative in understanding synaptic basis of neuropsychiatric disease
- Visit to the Berlin School of Mind and Brain
- Institute of Neurology ranked as the world’s top institution for epilepsy research.
- Predicting age at onset in SCA1 : does size matter?
- UCL takes the lead with £8.5m funding for dementia research
- Secretary of State visits leading dementia research projects
- Riboflavin Treatment for Childhood onset Motor Neuron Disease
- Dreading pain can be worse than pain itself
- Different gene expression in male and female brains helps explain differences in brain disorders
- New £20m centre pioneers first-in-man trials for neurodegenerative diseases
- RNA build-up linked to dementia and motor neuron disease
- Researchers estimate one in 2,000 people in the UK carry variant CJD proteins
- Professor Alan Thompson discusses Atlas of MS on Lancet News
- Wellcome Trust Principal Fellowship award to explore neural coding with the tripartite synapse
- Marsden's Book of Movement Disorders wins Neurology first prize at the 2013 BMA Book Awards
- Scientists develop refined diagnostic tool for inherited dementias
- Genetic mutations linked to Parkinson's Disease
- P-glycoprotein over-activity and drug resistance in temporal lobe epilepsy
- New Yale-UCL collaboration in brain aneurysm genetics
- ‘Risky’ stroke prevention procedure may be safe in some patients
- The Michael J. Fox Foundation awards grant for Exenatide research
- Institute Professor leads cross-disciplinary study on use of glucose in detecting cancer.
- Irreversible tissue loss seen within 40 days of spinal cord injury
- From Bedside to Bench in the Institute’s MRC Centre for Neuromuscular Diseases
- Centralising acute stroke services has saved more than 400 lives since 2010
- Rapid Response Innovation Award from The Michael J. Fox Foundation
- Predicting Language Outcome and Recovery After Stroke (PLORAS) project launches new website
- BRC awards over £500k to neuroscience projects
- ABTA Winners
- Diabetes drug could help treat Parkinson's Disease
- Clinical trials are vital tools in stroke research
- New gene identified for Dominant Congenital Spinal Muscular Atrophy and Hereditary Spastic Paraparesis
- Teaching Awards 2013
- 14th Annual Queen Square Symposium
- TRACK-HD study identifies early predictors of disease progression in Huntington’s disease
- The Great Brain Experiment: crowdsourcing data on how we think and act
- Psychogenic diseases linked to abnormal brain activity
- Human Brain Project wins major EU funding
- Gene mutation causes familial form of cranio-cervical dystonia
- Professor Ray Dolan awarded prestigious Klaus Joachim Zülch Prize
- Professor Dimitri Kullmann elected Editor of Brain
- IoN News Archive (2012)
- IoN News Archive (2011)
- IoN News Archive (2010)
- IoN News Archive (2009)
Published: Feb 14, 2014 4:38:40 PM
Published: Nov 6, 2013 4:39:40 PM
Published: Feb 24, 2014 2:53:53 PM
Published: Sep 16, 2013 1:37:21 PM
Published: Sep 20, 2013 12:43:48 PM
Published: Feb 20, 2014 6:58:34 PM
Published: May 11, 2013 3:39:00 PM
Published: Jan 16, 2014 12:32:49 PM
‘Risky’ stroke prevention procedure may be safe in some patients
12 July 2013
A major study published in the latest issue of Lancet Neurology, led by researchers at UCL's Institute of Neurology and funded by the Medical Research Council (MRC) and the Stroke Association, has found that stenting in the carotid artery is as safe as carotid artery surgery at reducing stroke risk in some patients.
The research, which was part of the International Carotid Stenting Study (ICSS), reveals that stenting is equally as safe as surgery in patients who show few signs of changes to brain tissue (known as white matter lesions) in a brain scan. However, patients whose brain scans do reveal changes to brain tissue, potentially caused by ageing or conditions such as high blood pressure, should not be treated by stenting. The study highlights the importance of carrying out brain scans in patients undergoing either procedure in order to determine which is most suitable.
One in five strokes are caused by narrowing of the carotid arteries due to a build-up of fatty deposits on the artery walls. However, the risk of stroke can be reduced by surgery to clean out the deposits or through stenting to widen the artery. Both procedures carry risks and in a minority of cases they can cause a stroke at the time of treatment. Earlier results from the ICSS have shown that although stenting is less invasive than surgery, the associated risks of stroke are higher.
This study looked for white matter lesions in the brain scans of patients taken before they underwent either surgery or stenting. One in ten patients with a greater than average number of white matter lesions had a stroke within 30 days of stenting treatment - three times higher than the risk of stroke after surgery. In contrast, in patients with less white matter damage, the risk of stroke was much lower and the same after both stenting and surgery.
Professor Martin Brown, the Chief Investigator of ICSS comments;
“The results of this trial demonstrate convincingly for the first time that the severity of white matter damage shown on CT or MRI brain scans should be taken into account when patients are offered treatment for carotid artery narrowing.
“Until now there has not been any conclusive way to select patients for stenting rather than surgery, although it was known that stenting was riskiest in older patients. This research suggests that patients with less than average amounts of white matter damage can be safely treated with stenting rather than surgery, but surgery should be the preferred treatment in patients with more extensive white matter damage on a brain scan.”
ICSS was run from University College London and included 50 hospital centres from Europe, Canada, Australia and New Zealand. 14 hospitals in the UK took part. Patients were recruited if they were found to have significant narrowing of a carotid artery that had already caused a stroke from which the patient had made a good recovery. Half the patients were randomly allocated treatment of the carotid narrowing by stenting and half were allocated surgery and were then seen regularly to find out how they got on.
Ederle, J. et al. Effect of white-matter lesions on the risk of periprocedural stroke after carotid artery stenting versus endarterectomy in the International Carotid Stenting Study (ICSS): a prespecified analysis of data from a randomised trial. Lancet Neurology. Available online 12th July 2013. DOI: 10.1016/S1474-4422(13)70135-2
Page last modified on 17 jul 13 20:48